AGP Picks
View all

Healthcare Focus Montserrat
Provided by AGP

Healthcare Focus Montserrat: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Focus Montserrat.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 4, 2026

Neuronetics Reports Third Quarter 2026 Financial and Operating Results
24 minutes ago

Neuronetics Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire
Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference
an hour ago

Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
an hour ago

Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum

Indeterminate GlobeNewswire
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
an hour ago

NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

Indeterminate GlobeNewswire
Cerenome Secures National In-Network Agreement with Aetna for CNSide®
an hour ago

Cerenome Secures National In-Network Agreement with Aetna for CNSide®

Indeterminate GlobeNewswire
Medline Reports Third Quarter and Nine Months 2026 Results
an hour ago

Medline Reports Third Quarter and Nine Months 2026 Results

Indeterminate GlobeNewswire
Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile
an hour ago

Harmony Biosciences Reports Q3 Financial Results on Track to Achieve More Than $1 Billion WAKIX Net Revenue and Announces Strong Multiple-Ascending Dose Data for Its Orexin Agonist BP-205, Supporting Potential Best-in-Class Profile

Indeterminate GlobeNewswire
Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium
an hour ago

Immuneering to Highlight Atebimetinib’s Broad Potential for Combinations in Pancreatic and Anaplastic Thyroid Cancers at the 2026 EORTC-NCI-AACR Symposium

Indeterminate GlobeNewswire
MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director
an hour ago

MediPharm Labs Appoints Greg Hunter as Chief Executive Officer and Director

Indeterminate GlobeNewswire
Kane Announces Publication of Real-World Evidence in the International Wound Journal
an hour ago

Kane Announces Publication of Real-World Evidence in the International Wound Journal

Indeterminate GlobeNewswire
uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update
an hour ago

uniQure Announces Third Quarter 2026 Financial Results and Provides Company Update

Indeterminate GlobeNewswire
Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update
an hour ago

Lifecore Biomedical Reports Financial Results for the Third Quarter Ended September 30, 2026, and Provides Corporate Update

Indeterminate GlobeNewswire
Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights
an hour ago

Geron Corporation Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire
AC Immune Third Quarter 2026 Financial and Corporate Update
an hour ago

AC Immune Third Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update
an hour ago

MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update

Indeterminate GlobeNewswire
Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases
an hour ago

Radiopharm Theranostics Announces Alignment with U.S. FDA on Single Pivotal Phase 3 Trial for RAD101 in Diagnosis of Brain Metastases

Indeterminate GlobeNewswire
Sironax Announces Two Abstracts on NAMPT Activator SIR4156 Selected for Presentation at ObesityWeek 2026
an hour ago

Sironax Announces Two Abstracts on NAMPT Activator SIR4156 Selected for Presentation at ObesityWeek 2026

Indeterminate GlobeNewswire
Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
an hour ago

Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026
an hour ago

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2026

Indeterminate GlobeNewswire
BioCryst Reports Third Quarter 2026 Financial Results
an hour ago

BioCryst Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Focus Montserrat

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.